High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 3, 2009, Pages 395-402

  Rivera, Margarita ^a   Gutiérrez, Blanca ^a   Molina, Esther ^a   Torres González, Francisco ^a   Belión, Juan A ^b   Moreno Küstner, Berta ^b   King, Michael ^c   Nazareth, Irwin ^c   Martínez González, Luis J ^a   Marífnez Espín, Esther ^a   Muñoz García, María M ^a   Motríco, Emma ^b   Martínez Cañavate, Teresa ^d   Lorente, José A ^a   Luna, Juan D ^a   Cervilla, Jorge A ^a,e  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Fundacion IAVANTE   (Spain)

^e UNIVERSITY OF GRANADA   (Spain)

Author keywords

Association study; Depression; MAOA; Umaoa polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; ALLELES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEPRESSION; DNA; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; ODDS RATIO; POLYMORPHISM, GENETIC; PRIMARY HEALTH CARE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 63449111838     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30829     Document Type: Article

References (32)

1. Akerblom HK, Uhari M, Pesonen E, Dahl M, Kaprio EA, Nuutinen EM, Pietikäinen M, Salo MK, Aromaa A, Kannas L, Keltikangas-Jarvinen L, Kuusela V, Räsänen L, Rönnemaa T, Knip M, Telama R, Välimäi I, Pyörälä K, Viikari J. 1991. Cardiovascular risk in young Finns. Ann Med 23:35-39.
2. Aragones E, Pinol JL, Labad A, Masdeu RM, Pino M, Cervera J. 2004. Prevalence and determinants of depressive disorders in primary care practice in Spain. Int J Psychiatry Med 34:21-35.
3. Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC. 1988. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934-4938.
4. Berry MD, Juorio AV, Paterson IA. 1994. The functional role of mono-amine oxidases A and B in the mammalian central nervous system. Prog Neurobiol 42:375-391.
5. Brummett BH, Krystal AD, Siegler IC, Kuhn C, Surwit RS, Zuchner S, shley-Koch A, Barefoot JC, Williams RB. 2007. Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med 69:396-401.
6. Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, de Dios LJ, Lorente JA, de Diego-Otero Y, King M, Nazareth I, Gutierrez
7. B. 2006. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: The PREDICT-gene study. Am J Med Genet Part B 141B:912-917.
8. Christiansen L, Tan QH, Iachina M, Bathum L, Kruse TA, Mcgue M, Christensen K. 2007. Candidate gene polymorphisms in the serotonergic pathway: Influence on depression symptomatology in an elderly population. Biol Psychiatry 61:223-230.
9. Contini V, Marques FZ, Garcia CE, Hutz MH, Bau CH. 2006. MAOA-uVNTR polymorphism in a Brazilian sample: Further support for the association with impulsive behaviors and alcohol dependence. Am J Med Genet Part B 141B:305-308.
10. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity mono-amine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
11. Denney RM, Koch H, Craig IW. 1999. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 105:542-551.
12. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, Riemann R, Spinath F, Craig 1.2003. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet Part B 120B:90-96.
13. Frieling H, Bleich S. 2006. Tranylcypromine: New perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci 256:268-273.
14. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. 1999. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promotor. Am J Med Genet 88:398-406.
15. Gabarrón Hortal E, Vidal Royo J, Haro Abad JM, Boix Soriano I, Jover Blanca A, Arenas Prat M. 2002. Prevalence and detection of depressive disorders in primary care. Atención Primaria 29:329-336.
16. Gutierrez B, Arias B, Gasto C, Catalan R, Papiol S, Pintor L, Fananas L. 2004. Association analysis between a functional polymorphism in the mono-amine oxidase A gene promoter and severe mood disorders. Psychiatr Genet 14:203-208.
17. Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. 2000. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 96:36-42.
18. Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase-A gene determines levels of enzyme-activity. Am J Hum Genet 49:383-392.
19. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. 2004. An association between a functional polymorphism in the monoamine oxidase A gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 29:1498-1505.
20. Jacob CP, Muller J, Schmidt M, Hohenberger K, Gutknecht L, Reif A, Schmidtke A, Mossner R, Lesch KP. 2005. Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology 30:1711-1718.
21. Jollant F, Buresi C, Guillaume S, Jaussent I, Bellivier F, Leboyer M, Castelnau D, Malafosse A, Courtet P. 2007. The influence of four serotonin-related genes on decision-making in suicide attempters. Am J Med Genet Part B 144B:615-624.
22. King M, Weich S, Torres-Gonalez F, Svab I, Maaroos HI, Neeleman J, Xavier M, Morris R, Walker C, Bellon-Saameno JA, Moreno-Kustner B, Rotar D, Rifel J, Aluoja A, Kalda R, Geerlings MI, Carraca I, de Almeida MC, Vicente B, Saldivia S, Rioseco P, Nazareth I. 2006. Prediction of depression in European general practice attendees: The PREDICT study. Bmc Public Health 6:6.
23. Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M, Hirose T, Nanko S. 1999. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 4:393-395.
24. Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF. 2000. A regulatory polymorphism of the monoamine oxidase-A gene maybe associated with variability in aggression, impulsivity, and central nervous system sero-tonergic responsivity. Psychiat Res 95:9-23.
25. Muramatsu T, Matsushita S, Kanba S, Higuchi S, Manki H, Suzuki E, Asai M. 1997. Monoamine oxidase genes polymorphisms and mood disorder. Am J Med Genet 74:494-496.
26. Nolen WA. 2003. Classical monoamine oxidase inhibitor: Not registered for, but still a place in the treatment of depression. Ned Tijdschr Geneeskd 147:1940-1943.
27. Papakostas GI, Fava M. 2006. A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Can J Psychiatry 51:783-790.
28. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
29. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grassle M, Papassotiropoulos A, Heun R, Nothen MM, Maier W, Lesch KP, Rietschel M. 2000. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96:801-803.
30. Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E, Lorenzi C, Corradi B, Grieco G, Costa A, Santorelli F, Barale F, Nappi G, Smeraldi E. 2002. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 Polymorphisms in mood disorders. Am J Med Genet 114:361-369.
31. Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M, Jungkunz G, Okladnova O, Meyer J, Lesch KP. 2001. Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105:168-171.
32. Yu YWY, Tsai SJ, Hong CJ, Chen TJ, Chen MC, Yang CW. 2005. Association study of a Monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsycho-pharmacology 30:1719-1723.